Drug Profile
CYT 007 TNFQb
Alternative Names: CYT007-TNFQbLatest Information Update: 19 Sep 2008
Price :
$50
*
At a glance
- Originator Cytos Biotechnology
- Class Antipsoriatics; Antirheumatics; Vaccines
- Mechanism of Action Immunomodulators; Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psoriasis; Rheumatoid arthritis